Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Bis tetrahydroisoquinoline. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel bis-tetrahydroisoquinoline intermediate synthesis improves yield and reduces cost for anticancer alkaloid manufacturing.
Patent CN103304478A details a high-yield Pictet-Spengler route for bis-tetrahydroisoquinoline alkaloids, offering cost-effective API intermediate manufacturing solutions.
Patent CN103709101B details efficient synthesis of renieramycin G intermediates via Pictet-Spengler reaction offering scalable supply chain solutions for pharmaceutical manufacturing.
Patent CN103709101B reveals efficient Pictet-Spengler route for renieramycin G intermediates. Enables cost reduction and scalable supply for anticancer drug development projects globally.